Pfizer strikes $5.2bn eczema firm deal

NewsBritish Broadcasting CorporationBBC Business News • Pfizer strikes $5.2bn eczema firm deal
Drugmaker Pfizer will acquire the maker of a new eczema treatment in a deal worth $5.2bn (£3.6bn).
To Share - Use this Perma Link